Tau profiling across Alzheimer’s disease staging reveals vulnerability to disease pathophysiology
Gleb Bezgin(Montreal Neurological Institute and Hospital), Pedro Rosa‐Neto(Montreal Neurological Institute and Hospital), Mira Chamoun(Douglas Mental Health University Institute), Joseph Therriault(Douglas Mental Health University Institute), Paolo Vitali(McGill University), Mélissa Savard(McGill University Health Centre), Min Su Kang(Douglas Mental Health University Institute), Gassan Massarweh(McGill University), Jean‐Paul Soucy(Montreal Neurological Institute and Hospital), Sulantha Mathotaarachchi(Montreal Neurological Institute and Hospital), Jaime Fernandez‐Arias(Douglas Mental Health University Institute), Vanessa Pallen(McGill University), Nesrine Rahmouni(McGill University), Arthur C. Macedo(McGill University), Thomas K. Karikari(University of Pittsburgh), Peter Kunach(Montreal Neurological Institute and Hospital), Brandon J. Hall(Montreal Neurological Institute and Hospital), Tatsuhiro Terada(Hamamatsu University School of Medicine), Stijn Servaes(Douglas Mental Health University Institute), Firoza Z Lussier(McGill University), Julie Ottoy(Sunnybrook Health Science Centre), Cécile Tissot(Hirslanden Clinique des Grangettes), Étienne Aumont(Université du Québec à Montréal), Yi-Ting Wang(McGill University Health Centre), Alyssa Stevenson(Douglas Mental Health University Institute), Nicholas J. Ashton(King's College London), Andréa Lessa Benedet(McGill University Health Centre), Seyyed Ali Hosseini(McGill University Health Centre), Serge Gauthier(McGill University Health Centre), Jenna Stevenson(McGill University), Kaj Blennow(University of Gothenburg), Henrik Zetterberg(University of Gothenburg), Yasser Iturria‐Medina(Cuban Neuroscience Center), Nina Margherita Poltronetti(McGill University), Tharick A. Pascoal(Montreal Neurological Institute and Hospital)
Cited by 3
Related Papers
Situating the default-mode network along a principal gradient of macroscale cortical organization
|Proceedings of the National Academy of Sciences|2016|2.6k
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
|The Lancet Neurology|2020|1.3k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554